-
Mercados
-
Acções
Sustainable finance2025 Euronext ESG Trends ReportRead moreA data-driven snapshot of how Euronext-listed companies are advancing their Environmental, Social and Governance (ESG) practices.
-
índices
A milestone in a decade of transformationEuronext joins the CAC 40®Read moreAs of 22 September 2025, Euronext has officially joined the CAC 40®, France’s flagship blue-chip index.
-
ETFs
The European market place for ETFsEuronext ETF EuropeRead moreInvestors benefit from a centralised market place that will not only bring transparency but also better pricing due to the grouping of liquidity.
- Fundos
-
Obrigações
European Defence BondsGroupe BPCE lists the first bondRead moreFirst financial institution in Europe to issue a bond dedicated to the defence sector
- Warrants & Certificados
-
Derivados
Where European Government Bonds Meet the FutureFixed Income derivativesRead moreTrade mini bond futures on main European government bonds
-
Matérias-Primas
- Vista global
- Quotes snapshot
- Power Derivatives
- Milling Wheat derivatives
- Corn derivatives
- Spread contracts
- Rapeseed derivatives
- Durum Wheat derivatives
- Salmon derivatives
- Entrega e liquidação
- Especificações e disposições
- Commitments of Traders (CoT) report
- Commodity brokers
Building a sustainable and liquid power derivatives market.Euronext Nord Pool Power FuturesRead moreEuronext and Nord Pool, the European power exchange, announced the launch of a dedicated Nordic and Baltic power futures market.
-
Recursos
Designed to help students navigate the complexities of financial marketsEuronext Trading gameRead moreJoin the Euronext Trading Game and step into capital markets. Learn from today’s leaders, explore sustainable opportunities, and trade with confidence.
Company press releases
| Released | Company | Title | Industry | Topic |
|---|---|---|---|---|
| 18 Sep 2023 18:40 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 26 Aug 2023 09:40 CEST |
VISTIN PHARMA | Mandatory notification of trade in Vistin Pharma ASA | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 23 Aug 2023 07:35 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Second quarter and first half 2023 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 16 Aug 2023 12:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q2 2023 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 04 Jul 2023 08:30 CEST |
VISTIN PHARMA | Management in Vistin Pharma ASA purchases shares | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 04 Jul 2023 08:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Results of offer to buy back shares | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 30 Jun 2023 07:30 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Offer to buy back shares | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Jun 2023 13:57 CEST |
VISTIN PHARMA | Financial calendar | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 22 Jun 2023 13:57 CEST |
VISTIN PHARMA | Finansiell kalender | 20103015 Pharmaceuticals | Annen informasjonspliktig regulatorisk informasjon |
| 14 Jun 2023 15:15 CEST |
VISTIN PHARMA | Vistin Pharma ASA (OSE: VISTIN): Presentation from today's Capital Markets Day | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 31 May 2023 12:05 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 30 May 2023 21:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Mandatory notification of trade | 20103015 Pharmaceuticals | Mandatory notification of trade primary insiders |
| 22 May 2023 14:52 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Minutes from the Annual General Meeting 2023 | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 11 May 2023 11:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA (OSE: VISTIN): Invitation to Capital Markets Day on 14th of June at the metformin manufacturing plant in Kragerø | 20103015 Pharmaceuticals | Non-regulatory press releases |
| 28 Apr 2023 12:30 CEST |
VISTIN PHARMA | Notice of Annual General Meeting in Vistin Pharma ASA | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 27 Apr 2023 17:35 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Annual Report for 2022 | 20103015 Pharmaceuticals | Annual financial and audit Reports |
| 27 Apr 2023 07:50 CEST |
VISTIN PHARMA | Vistin Pharma ASA: First quarter 2023 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 20 Apr 2023 11:00 CEST |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q1 2023 conference call | 20103015 Pharmaceuticals | Additional regulated information required to be disclosed under the laws of a Member State |
| 17 Feb 2023 08:00 CET |
VISTIN PHARMA | Vistin Pharma ASA: Fourth quarter and preliminary 2022 financial results | 20103015 Pharmaceuticals | Half yearly financial reports and audit reports/limited reviews |
| 10 Feb 2023 10:00 CET |
VISTIN PHARMA | Vistin Pharma ASA: Invitation to Q4 2022 conference call | 20103015 Pharmaceuticals | Non-regulatory press releases |